Insulin stimulates glucose uptake in adipose and muscle cells via translocation of the intracellular vesicles containing GLUT4. It was largely unknown whether and/or how the signaling molecules such as PI 3-kinase and Akt regulate the mechanical movements of the GLUT4-containing vesicles. Hence, this study was performed to test the hypothesis that actin and microtubules function in translocating GLUT4 vesicles. Treatments of insulin as well as endothelin-1 (ET-1), an insulin-mimicking peptide which does not act through PI 3-kinase, induced polymerization of actin without affecting the microtubular network. By mass spectrometry, the tyrosine kinase PYK2 was identified to be tyrosine phosphorylated specifically by ET-1 but not by insulin. Expression of the carboxyl-terminal fragment (CRNK) PYK2, but not wild type nor kinase-deficient PYK2 mutants, inhibited ET-1-stimulated actin polymerization while expression of all three PYK2 constructs had no effect on insulin-stimulated actin polymerization. More importantly, expression of CRNK, but not wild type nor kinase-deficient PYK2 constructs, blocked ET-1- but not insulin-stimulated GLUT4 translocation to the plasma membrane. These suggest that ET-1 and insulin stimulate actin polymerization via distinct signaling pathways, and that the actin polymerization is required for GLUT4 vesicle translocation. In order to test the possible involvement of microtubule in GLUT4 vesicle translocation, time lapse imaging of 3T3-L1 adipocytes expressing GLUT4-YFP and tubulin-CFP was performed. GLUT4-YFP vesicles move long-range bi-directionally on microtubules, which suggests the presence of molecular motors on the vesicles. Moreover, insulin increased the number of vesicle movements on microtubules without changing the velocities. Interestingly, the stimulatory action of insulin appears to be independent of PI 3-kinase activation. Conventional kinesin was identified as a highly expressed kinesin isotype in adipocytes. Notably, expression of dominant negative mutants but not wild type kinesin inhibited insulin-stimulated long-range GLUT4 vesicle movements and GLUT4 translocation to the plasma membrane in live and fixed cells, respectively. These data indicate that insulin signaling induces the movement of GLUT4 vesicles on microtubule which is mediated by conventional kinesin. Overall, the data presented here provide evidence supporting the hypothesis that actin and microtubule cytoskeletons are required for insulin to mobilize GLUT4 vesicles in adipocytes.

This thesis examines the hypothesis that human erythrocyte net sugar transport is the sum of two serial processes: sugar translocation followed by interaction of newly imported sugar with an intracellular binding complex from which sugar dissociates into the bulk cytosol. This hypothesis suggests that steady-state transport measurements in the human erythrocyte do not accurately reflect the intrinsic catalytic features of the glucose transporter and unless correctly interpreted, may lead to apparent inconsistencies in the operational behavior of the human erythrocyte sugar transport system. Our results support this proposal by demonstrating that although sugar transport measurements in human red blood cells suggest that transport is catalytically asymmetric, ligand binding measurements indicate that transport must be symmetric. In order to examine the serial compartments hypothesis, we set out to determine the following: 1) identify the component(s) of the proposed sugar binding complex, 2) determine whether cytosolic ATP levels and transporter quaternary structure affect sugar binding to the sugar binding complex, and 3) determine whether the sugar binding site(s) are located within or outside the cell. We present findings which support the hypothesis that the sugar binding complex is in fact the sugar transport protein, GLUT1. The number of sugar binding sites and the release of sugar from the GLUT1 complex are regulated by ATP and by GLUT1 quaternary structure. The sugar binding sites are located on a cytoplasmic domain of the GLUT1 complex. We show how these observations can account for the apparent complexity of erythrocyte sugar transport and its regulation by ATP.

No description available.

No description available.

No description available.

No description available.

Systemic glucose regulation is essential for human survival as low or chronically high glucose levels can be detrimental to the health of an individual. Glucose levels are highly regulated via inter-organ communication networks that alter metabolic function to maintain euglycemia. For example, when nutrient levels are low, pancreatic α-cells secrete glucagon, which signals to the liver to promote glycogen breakdown and glucose production. In times of excess nutrient intake, pancreatic β-cells release insulin. Insulin signals to the liver to suppress hepatic glucose production, and signals to the adipose tissue and the skeletal muscle to take up excess glucose via insulin-regulated glucose transporters. Defects in this inter-organ communication network including insulin resistance can result in glucose deregulation and ultimately the onset of type-2 diabetes (T2D). To identify novel regulators of insulin-mediated glucose transport, our laboratory performed an siRNA-mediated gene-silencing screen in cultured adipocytes and measured insulin-mediated glucose transport. Gene silencing of Mitogen-activated protein kinase kinase kinase kinase 4 (Map4k4), a Sterile-20-related serine/threonine protein kinase, enhanced insulin-stimulated glucose transport, suggesting Map4k4 inhibits insulin action and glucose transport. Thus, for the first part of my thesis, I explore the role of Map4k4 in cultured adipose cells and show that Map4k4 also represses lipid synthesis independent of its effects on glucose transport. Map4k4 inhibits lipid synthesis in a Mechanistic target of rapamycin complex 1 (mTORC1)- and Sterol regulatory element-binding transcription factor 1 (Srebp-1)-dependent mechanism and not via a c-Jun NH2-terminal kinase (Jnk)-dependent mechanism. For the second part of my thesis, I explore the metabolic function of Map4k4 in vivo. Using mice with loxP sites flanking the Map4k4 allele and a ubiquitously expressed tamoxifen-activated Cre, we inducibly ablated Map4k4 expression in adult mice and found significant improvements in metabolic health indicated by improved fasting glucose and whole-body insulin action. To assess the role of Map4k4 in specific metabolic tissues responsible for systemic glucose regulation, we employed tissue-specific knockout mice to deplete Map4k4 in adipose tissue using an adiponectin-cre transgene, liver using an albumin-cre transgene, and skeletal muscle using a Myf5-cre transgene. Ablation of Map4k4 expression in adipose tissue or liver had no impact on whole body glucose homeostasis or insulin resistance. However, we surprisingly found that Map4k4 depletion in Myf5-positive tissues, which include skeletal muscles, largely recapitulates the metabolic phenotypes observed in systemic Map4k4 knockout mice, restoring obesity-induced glucose intolerance and insulin resistance. Furthermore these metabolic changes were associated with enhanced insulin signaling to Akt in the visceral adipose tissue, a tissue that is nearly devoid of Myf5-positive cells and does not display changes in Map4k4 expression. Thus, these results indicate that Map4k4 in Myf5-positive cells, most likely skeletal muscle cells, inhibits whole-body insulin action and these effects may be mediated via an indirect effect on the visceral adipose tissue. The results presented here provide evidence for Map4k4 as a potential therapeutic target for the treatment of insulin resistance and T2D.

A cana-de-açúcar vem assumindo um papel de destaque na atual conjuntura nacional, impulsionada principalmente pela produção de etanol, que vai de encontro com a crescente preocupação mundial na busca por fontes de energias renováveis e menos impactantes ao ambiente. Por essa razão, é preciso assegurar o contínuo desenvolvimento técnico-científico do setor sucroalcooleiro nacional, mantendo o Brasil na posição de vanguarda na produção de biocombustíveis. Ante a disponibilidade de inúmeras ferramentas biotecnológicas, tornou-se possível avançar com maior celeridade na compreensão dos campos da genética e fisiologia da cana-de-açúcar. Neste trabalho é demonstrado a transformação genética via biobalística da cultivar RB835486. No processo foram usadas duas construções para silenciamento gênico via RNA de interferência (RNAi), com genes quiméricos do tipo shRNA (short harpin RNA) para silenciamento dos genes SspTIP1;1 e SspPIP1;4, em co-tranformação com o gene marcador npt- II. Os dois genes alvo selecionados codificam aquaporinas, proteínas transmembrana responsáveis pelo transporte de água na planta. Estes genes foram identificados anteriormente por seu possível envolvimento no processo de acúmulo de sacarose. A co-integração dos cassetes de silenciamento gênico e do gene marcador ocorreu em 13 plantas, sendo obtidas três linhagens para o gene SspTIP1;1 e 10 linhagens para o gene SspPIP1;4. Dentre elas, duas linhagens SspTIP1;1 e cinco linhagens SspPIP1;4 foram analisadas via RT-PCR, quanto a possíveis modificações nos níveis de expressão dos genes alvos. Nas duas linhagens transgênicas avaliadas para silenciamento do SspTIP1;1, não houve redução em sua expressão em relação ao controle não transformado, possivelmente devido a efeitos de posição. Nas outras cinco linhagens transgênicas avaliadas para silenciamento do SspPIP1;4, houve redução significativa em seus níveis de expressão em três linhagens em relação ao controle não transformado. Nestas plantas serão realizadas as análises fisiológicas a fim de validá-las funcionalmente quanto ao transporte de água e acúmulo de sacarose. / Sugarcane has taken a leading role in the current national economy, mainly boosted by ethanol production, which meet the growing global concern on searching for renewable energy and with low impact on the environment. Therefore, it is necessary to ensure the continuous technical and scientific development of the national sugar and ethanol sector, maintaining the leading position of Brazil in biofuel production. By the availability of numerous biotechnology tools, it became possible to advance more rapidly in understanding the fields of genetics and physiology of sugarcane. This work demonstrated the genetic transformation of the cultivar RB835486 via biolistic assay. In the process it was used two constructs for gene silencing via RNA interference (RNAi) with chimeric genes of the type shRNA (short harpin RNA) for silencing of the genes SspTIP1;1 and SspPIP1;4, co-transformed with the marker gene npt- II. The two selected target genes encode aquaporins, transmembrane proteins which are responsible for water transport in plants. These genes were previously identified for their possible involvement in the process of sucrose accumulation. The co-integration of both, the cassette gene silencing and gene marker was observed in 13 plants, three strains were obtained for the gene SspTIP1;1 and 10 strains for gene SspPIP1;4. Among them, two strains of SspTIP1;1 and five strains of SspPIP1;4 were analyzed by RT-PCR, searching for possible changes in the levels of target gene expression. In the two transgenic lines evaluated for silencing SspTIP1;1, no reduction in expression compared to control non-transformed was obtained, possibly due to effects of position insertion of the gene in the genome. The other five transgenic lines evaluated for silencing of SspPIP1;4, a significant reduction in their expression levels was obtained in three strains when compared to the control untransformed plants. These silenced plants will be physiologically analyzed to validate their function on water transport and sucrose accumulation.

O genoma de Xanthomonas citri (Xac) possui mais de 20 tipos de transportadores do tipo ABC incluindo o operon ssuABC associado ao transporte de alcano sulfonatos. Deste operon, escolhemos a proteína periplasmática ligadora de alcano sulfonatos SsuA2, para caracterização e análises espectroscópicas e estruturais. A rSsuA2 foi expressa no citoplasma de células de Escherichia coli e utilizada para a preparação de anticorpos em camundongos, que foram capazes de reconhecer a proteína recombinante, mas não a nativa no extrato de células de Xac. A rSssuA2 apresenta estrutura característica de proteínas alfa-beta, maior estabilidade em pH neutro (7.0), como também foi evidenciado pela obtenção de cristais somente nesta faixa, e pouca flexibilidade ao desenovelamento térmico. Os cristais difratam com resolução de 1.8 Å e pertencem ao grupo espacial de simetria P21. Além do o operon ssu (ssu2) altamente conservado, Xac apresenta o operon tau (ssu1) para captação de taurina. O papel do operon para Xac é discutido. / Xanthomonas citri (Xac) genome has more than 20 different ABC transporters, including the ssuABC operon. In this work, the alkanosulphonate-periplasmic binding protein SsuA2 was chosen for spectroscopic and structural analysis. The rSsuA2 protein was expressed as a soluble form and purified by immobilized metal affinity chromatography. Antibodies produced from the recombinant protein were able to recognize the rSsuA2, but not the native protein in the Xac extract samples. The protein presents secondary structure defined by alfa helices and beta-sheets, high stability in neutral pH and low flexibility to the thermal denaturation. The determination of the optimal pH range was important to produce crystals of high quality diffracting at 1.8 Å with symmetry of the P21 spatial group. Besides the highly conserved operon ssu (ssu2), Xac has the tau operon (ssu1) for taurine uptake.

by Chan Ka Kui. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2000. / Includes bibliographical references (leaves 104-113). / Abstracts in English and Chinese. / ABSTRACT --- p.1 / Chapter 1 --- INTRODUCTION --- p.5 / Chapter 1.1 --- Incidence rate of breast cancer in Hong Kong --- p.5 / Chapter 1.2 --- Estrogen and breast cancer --- p.6 / Chapter 1.3 --- The relation between glucose transporters and breast cancer --- p.7 / Chapter 1.4 --- Antisense oligonucleotide --- p.10 / Chapter 1.5 --- Action mechanisms of antisense oligonucleotide --- p.11 / Chapter 1.6 --- Modification of the oligonucleotide --- p.13 / Chapter 1.7 --- Length --- p.16 / Chapter 1.8 --- Sequence selection of the antisense oligonucleotide --- p.16 / Chapter 1.9 --- Delivery means in antisense oligonucleotide --- p.18 / Chapter 1.10 --- The therapeutic role of antisense oligonucleotide --- p.19 / Chapter 1.11 --- Objective of the project --- p.21 / Chapter 2 --- MATERIAL AND METHODS --- p.23 / Chapter 2.1 --- Materials --- p.23 / Chapter 2.2 --- Methods --- p.26 / Chapter 3 --- RESULTS --- p.37 / Chapter 3.1 --- The characteristics of MCF-7 and MDA-MB-231 cells --- p.37 / Chapter 3.2 --- Trend of uptake of antisense oligonucleotides in MCF-7 and MDA- MB-231 cells --- p.41 / Chapter 3.3 --- The integrity of the oligonucleotide in serum-free medium during transfection --- p.48 / Chapter 3.4 --- Detection of effects of Glut5 antisense oligonucleotides of breast tumor cells-MTT assay --- p.50 / Chapter 3.5 --- Detection of the antiproliferative effect by trypan blue exclusion assay and thymidine incorporation --- p.56 / Chapter 3.6 --- Cell cycle analysis and DNA extraction --- p.61 / Chapter 3.7 --- Suppression of Glut5 mRNA detected by RT-PCR --- p.66 / Chapter 3.8 --- Suppression of translation of Glut5 proteins as indicated by Western blotting --- p.73 / Chapter 3.9 --- Measurement of the fructose and glucose uptake in MCF-7 and MDA -MB-231 cells after antisense treatment --- p.76 / Chapter 3.10 --- Change of the phosphofructokinase-1 (PFK-1) activities in MDA- MB-231 cells --- p.82 / Chapter 3.11 --- Measurement of the change in the intracellular pH of the breast tumor cells --- p.84 / Chapter 4 --- DISCUSSION --- p.89 / Chapter 4.1 --- The insights of Glut5 antisense oligonucleotide into cancer therapy --- p.89 / Chapter 4.2 --- The uptake pattern of Glut5 antisense oligonucleotides in breast tumor cells --- p.90 / Chapter 4.3 --- Stability of antisense oligonucleotide during transfection --- p.92 / Chapter 4.4 --- Effects of Glut5 antisense oligonucleotide on MCF-7 and MDA-MB- 231cells --- p.93 / Chapter 4.5 --- Proofs of undergoing antisense action mechanism --- p.95 / Chapter 4.6 --- Physiological changes in breast tumor cells after antisense treatment --- p.97 / Chapter 5 --- CONCLUSION --- p.103 / Chapter 6 --- References --- p.104